Senger DL - Search Results

1

Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin.

Lun X, Alain T, Zemp FJ, Zhou H, Rahman MM, Hamilton MG, McFadden G, Bell J, Senger DL, Forsyth PA. Lun X, et al. Among authors: senger dl. Cancer Res. 2010 Jan 15;70(2):598-608. doi: 10.1158/0008-5472.CAN-09-1510. Epub 2010 Jan 12. Cancer Res. 2010. PMID: 20068158

2

Reovirus as an oncolytic agent against experimental human malignant gliomas.

Wilcox ME, Yang W, Senger D, Rewcastle NB, Morris DG, Brasher PM, Shi ZQ, Johnston RN, Nishikawa S, Lee PW, Forsyth PA. Wilcox ME, et al. J Natl Cancer Inst. 2001 Jun 20;93(12):903-12. doi: 10.1093/jnci/93.12.903. J Natl Cancer Inst. 2001. PMID: 11416111

3

Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma.

Yang WQ, Senger D, Muzik H, Shi ZQ, Johnson D, Brasher PM, Rewcastle NB, Hamilton M, Rutka J, Wolff J, Wetmore C, Curran T, Lee PW, Forsyth PA. Yang WQ, et al. Cancer Res. 2003 Jun 15;63(12):3162-72. Cancer Res. 2003. PMID: 12810644

4

Long-term survivors of glioblastoma: statistical aberration or important unrecognized molecular subtype?

Senger D, Cairncross JG, Forsyth PA. Senger D, et al. Cancer J. 2003 May-Jun;9(3):214-21. doi: 10.1097/00130404-200305000-00009. Cancer J. 2003. PMID: 12952306 Review.

5

Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.

Vieyra D, Senger DL, Toyama T, Muzik H, Brasher PM, Johnston RN, Riabowol K, Forsyth PA. Vieyra D, et al. Among authors: senger dl. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5952-61. Clin Cancer Res. 2003. PMID: 14676120

6

Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer.

Yang WQ, Senger DL, Lun XQ, Muzik H, Shi ZQ, Dyck RH, Norman K, Brasher PM, Rewcastle NB, George D, Stewart D, Lee PW, Forsyth PA. Yang WQ, et al. Among authors: senger dl. Gene Ther. 2004 Nov;11(21):1579-89. doi: 10.1038/sj.gt.3302319. Gene Ther. 2004. PMID: 15372068

7

Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates.

Yang WQ, Lun X, Palmer CA, Wilcox ME, Muzik H, Shi ZQ, Dyck R, Coffey M, Thompson B, Hamilton M, Nishikawa SG, Brasher PM, Fonseca K, George D, Rewcastle NB, Johnston RN, Stewart D, Lee PW, Senger DL, Forsyth PA. Yang WQ, et al. Among authors: senger dl. Clin Cancer Res. 2004 Dec 15;10(24):8561-76. doi: 10.1158/1078-0432.CCR-04-0940. Clin Cancer Res. 2004. PMID: 15623640

8

Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.

Lun X, Yang W, Alain T, Shi ZQ, Muzik H, Barrett JW, McFadden G, Bell J, Hamilton MG, Senger DL, Forsyth PA. Lun X, et al. Among authors: senger dl. Cancer Res. 2005 Nov 1;65(21):9982-9990. doi: 10.1158/0008-5472.CAN-05-1201. Cancer Res. 2005. PMID: 16267023 Free PMC article.

9

Recent progress in the battle between oncolytic viruses and tumours.

Parato KA, Senger D, Forsyth PA, Bell JC. Parato KA, et al. Nat Rev Cancer. 2005 Dec;5(12):965-76. doi: 10.1038/nrc1750. Nat Rev Cancer. 2005. PMID: 16294217 Review.

10

Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.

Lun X, Senger DL, Alain T, Oprea A, Parato K, Stojdl D, Lichty B, Power A, Johnston RN, Hamilton M, Parney I, Bell JC, Forsyth PA. Lun X, et al. Among authors: senger dl. J Natl Cancer Inst. 2006 Nov 1;98(21):1546-57. doi: 10.1093/jnci/djj413. J Natl Cancer Inst. 2006. PMID: 17077357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters